Cover Image
市場調查報告書

連續式血糖監測(CGM):技術及全球市場

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

出版商 BCC Research 商品編碼 245912
出版日期 內容資訊 英文 172 Pages
訂單完成後即時交付
價格
Back to Top
連續式血糖監測(CGM):技術及全球市場 Continuous Glucose Monitoring (CGM): Technologies and Global Markets
出版日期: 2017年12月07日 內容資訊: 英文 172 Pages
簡介

全球連續式血糖監測儀(CGM)市場總額在2013年為2億7,940萬美金。該市場額預測從2014年到2019年這段期間將以年複合成長率19.6%的速度擴大,到2014年將達到3億2,090萬美元,2019年將達到7億8,390萬美元的規模。

本報告提供全球連續式血糖監測(CGM)市場相關的總括性調查,彙整包含世界市場趨勢,技術開發·各地區趨勢·市場動態·引進趨勢等重要的課題分析,各用途領域的市場明細,年齡·人種·各地區的資訊,及主要企業簡介等,為您概述為以下內容。

第1章 簡介

第2章 摘要

第3章 糖尿病的詳細分析

  • 胰臟的作用
  • 糖尿病的診斷
  • 糖尿病的類型
  • 全世界的肥胖及糖尿病的增加
  • 糖尿病的得病率和發生率
  • 血糖監測系統技術的歷史·現狀
  • 連續式血糖監測(CGM)系統的醫療保險·醫療費給付

第4章 產業結構

  • 胰島素幫浦提供企業
  • 血糖試紙的自我監測提供企業

第5章 主要市場

  • 連續式血糖監測(CGM)市場
  • 血糖儀表的自我監測·試紙市場
  • 價格·價格實際成果趨勢
  • 其他需求影響因素
  • 開業醫生·醫院用途的連續式血糖監測(CGM)

第6章 技術創新·開發平台·專利評估

  • 劃時代的大發現

第7章 主要臨床實驗

  • NICE-SUGAR實驗
  • MEDTRONIC的IN-CLINIC可行性研究,以觀察OVERNIGHT封閉迴路系統
  • 兒童及第一型糖尿病患者的自動封閉迴路型
  • 利用連續式血糖監測(CGM)的ICU的葡萄糖調節
  • 新的置入式連續式血糖監測器準確度的展望,多中心評估

第8章 企業簡介

  • ABBOTT DIABETES CARE INC.
  • ANIMAS CORP.
  • ARKRAY INC.
  • BAYER HEALTHCARE AG
  • BECTON, DICKINSON AND COMPANY
  • BRAUN MELSUNGEN AG
  • CEQUR SA
  • DEBIOTECH SA
  • DEXCOM INC.
  • EDWARDS LIFESCIENCES
  • GLYSENS INC.
  • INSULET CORP.
  • JOHNSON & JOHNSON
  • LABSTYLE INNOVATIONS CORP.
  • MEDTRONIC INC. MEDTRONIC DIABETES
  • MENARINI GROUP
  • ROCHE DIAGNOSTICS CORP.
  • SANOFI U.S.
  • SENSEONICS
  • TANDEM DIABETES CARE
  • VALERITAS

第9章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC102C

The global market for continuous glucose monitoring devices and diabetes-related products totaled nearly $12.1 billion in 2016. The market should reach nearly $12.8 billion in 2017 and $20.7 billion in 2022, registering a compound annual growth (CAGR) of 10.1% from 2017-2022.

Report Includes

  • 52 data tables and 20 additional tables
  • An overview of the global market for continuous glucose monitoring (CGM)
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of the critical issues within the CGM market, including technological developments, geographic trends, market dynamics, and adoption trends
  • Market breakdowns by application area: hospitals, diagnostics/clinics, home
  • Information broken down by age: children, teens, young, middle, elderly; by race: non-Hispanic whites, Hispanics, Asian-Americans, Europeans, Asians, others; and by geography: the U.S., Europe, Asia, and the rest of the world
  • Information on leading companies, including their product portfolios and recent developments

Report Scope

The scope of this study encompasses the current and forecast markets for glucose monitoring, as well as pumps, SMBG meters and test strips. The covered segments are CGM transmitters, receivers and sensors, patch and durable insulin pumps, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all usage of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM device. Calibration may be required once or twice a day, or even less often, as the devices improve in the near future. Inclusion of SMBG meters and test strips will help the reader to comprehend the relative sizes of the two major segments: CGM and SMBG. As discussed elsewhere in this report, developing countries will continue to use primarily SMBG, as these devices are not only much cheaper than CGM, but, for many diabetics, do just fine for monitoring blood glucose. The report also includes discussions of the reimbursement and regulatory environments, current and developing technologies, diabetes incidence, market projections and market shares, and the latest trends and clinical trials.

Analyst Credentials

Valerie Kellogg is an experienced medical device and pharmaceutical professional with international market research experience. She has authored numerous reports on topics ranging from the treatment of obesity to ablation devices, from wound care to the treatment of chronic migraine. Her strong focus areas include oncology, treatment of chronic disease, the latest in surgical devices and analysis of potential acquisitions.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports (marketing teams updated list)

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • History and Current State of Blood Glucose Monitoring Technology
    • SMBG Devices
    • Noninvasive Blood Glucose Monitoring
    • Electrochemical Blood Glucose Test Strips
    • Technical Challenges in Accurately Measuring Interstitial Glucose Levels
    • Use of Continuous Glucose Monitoring in Children with Type 1 Diabetes
    • Proving the Benefits of CGM Use by All Diabetics: T1D, T2D and Gestational Diabetes Patients
  • Working to Improve CGM Technology
    • Smart sensors improve accuracy of blood glucose readings.
    • Changing the Optimal Dosing Rules for Nonadjunctive CGM
    • Reducing the Number of Calibrations Needed
    • Detecting and Dealing with Faults
    • GlySens Inc. and the ICGM
    • Dexcom's G4 Platinum Professional CGM Device
    • Permanently Implanted Continuous Glucose Monitoring
    • Pumps: Not Yet the Perfect Technology
    • Government Regulations and Associations' Statements
  • Healthcare Insurance and Reimbursement for CGM Systems and Pumps.
    • United States
    • Canada
    • Europe
    • Asia
    • Rest of World
  • In-depth focus on diabetes
    • Role of the Pancreas
    • Diabetes Diagnosis
    • Types of Diabetes Mellitus
  • Global Obesity and the Rise of Diabetes
    • Prevalence and Incidence of Diabetes
    • Diabetes Treatment, Mortality and Economic Burden
    • Treatment of Diabetes
    • Artificial Pancreas

Chapter 4: Market Breakdown by Technology Type

  • Total Global Market, 2016 through 2022
  • Global CGM Markets
  • Global Insulin Pump Markets
  • Global SMBG Meters and Test Strips Markets

Chapter 5: Market Breakdown by Testing Location

  • U.S. CGM Market by End User
  • Canadian CGM Market by End User
  • European CGM Market by End User
  • Asian CGM Market by End User
  • ROW CGM Market by End User

Chapter 6: CGM and SMBG Markets by Type of Diabetes

  • CGM Markets by Type of Diabetes
    • Global CGM Markets by Type of Diabetes
    • U.S. CGM Market by Type of Diabetes
    • Canadian CGM Market by Type of Diabetes
    • European CGM Market by Type of Diabetes
    • Asian CGM Market by Type of Diabetes
    • ROW CGM Market by Type of Diabetes
  • SMBG and Test Strip Markets, by Type of Diabetes
    • Global SMBG and Test Strips Market by Type of Diabetes
    • U.S. SMBG and Test Strips Market by Type of Diabetes
    • Canadian SMBG and Test Strips Market by Type of Diabetes
    • European SMBG and Test Strips Market by Type of Diabetes
    • Asian SMBG and Test Strips Market by Type of Diabetes
    • ROW SMBG and Test Strips Market by Type of Diabetes

Chapter 7: CGM Markets by User's Age

  • U.S. CGM Market by User's Age
  • Canadian CGM Market by User's Age
  • European CGM Market by User's Age
  • Asian CGM Market by User's Age
  • ROW CGM Market by User's Age

Chapter 8: Market Breakdown by Region

  • Regional Markets for CGMs, Patch Pumps, Durable Pumps, SMBG Meters and Test Strips.
  • CGM Markets by Region
  • Insulin Pump Markets by Region.
    • Insulin Patch Pump Markets by Region
    • Insulin Durable Pump Markets by Region
  • SMBG Meters and Test Strip Markets by Region
    • SMBG Meter Markets by Region
    • Test Strip Markets by Region
  • U.S. Market
  • Canada
  • Europe
  • Asia
  • Rest of World

Chapter 9: Patent Review/ New Developments

  • Patent Review
  • New Developments
    • Medtronic MiniMed 670G System.
    • Tandem Predictive Low Glucose Suspend (PLGS) and Hybrid Closed Loop
    • Bigfoot Biomedical Smartloop Automated Insulin Delivery Service
    • Beta Bionics iLet Bionic Pancreas (Insulin-only and Insulin + Glucagon)
    • Animas Hypoglycemia-Hyperglycemia Minimizer
    • Insulet Omnipod Horizon

Chapter 10: Analysis of Market Opportunities.

  • Opportunities in the U.S. Market
    • Entering the U.S. CGM Market
    • Opportunities in SMBG and Test Strips
  • Opportunities in the Canadian Market
  • Opportunities in the European Market
  • Opportunities in the Asian Market
  • Opportunities in the Rest of World Markets

Chapter 11: Company Profiles

Appendix: CGM and Diabetes-related Device Markets

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for Continuous Glucose Monitoring Devices and Diabetes-related Products, by Type, Through 2022 ($ Millions)
  • Table 1 FDA 2016 Final Guidance for BGMS and SMBGs
  • Table 2 Selected Companies Developing or Launching Noninvasive Blood Glucose Monitoring Devices
  • Table 3 Selected International Blood Lancet Suppliers, 2016
  • Table 4 Characteristics of Selected CGM Systems
  • Table 5 Local Reimbursement and Guidelines for Self-Monitoring of Blood Glucose in Selected Central and Eastern European Countries, 2014
  • Table 6 Top 10 Most Obese OECD Countries, 2014
  • Table 7 WHO Obesity Levels and Rankings of Selected Countries, 201450 (%)
  • Table 8 Global Diabetes Population, 2015 and 2040
  • Table 9 Global Estimates of Undiagnosed Diabetics, 2015 (%/Millions)
  • Table 10 Global and Regional Age-Adjusted Comparative Diabetes Prevalence, 2015 and 2040 (%)
  • Table 11 Top 10 Countries with Respect to Diabetic Populations (Aged 20-79 Years), 2015 and 2040 (Millions)
  • Table 12 Age-Adjusted Prevalence of Diabetes Mellitus in the U.S., by Race and Ethnicity, Adults ≥20 Years of Age (%)
  • Table 13 Prevalence of Diabetes and Impaired Glucose Tolerance (IGT) in Different Regions of the World, 2015 (%)
  • Table 14 Adult Diabetes Trends, Through 2040 (Million Cases)
  • Table 15 Top 20 Countries with Respect to Prevalence of Diabetes, 2015 (%)
  • Table 16 Prevalence of Diabetes in Adults, Aged 20-79 in Developed Countries, 2015 (%)
  • Table 17 Global Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, Through 2022 ($ Millions)
  • Table 18 Global Market for CGM Transmitters and Receivers, and Sensors, Through 2022 ($ Millions)
  • Table 19 Global Market for Insulin Patch Pumps and Durable Pumps, Through 2022 ($ Millions)
  • Table 20 Global Market for SMBG Meters and Test Strips, Through 2022 ($ Millions)
  • Table 21 Global CGM Market in Home Setting, by Region, Through 2022 ($ Millions)
  • Table 22 Global CGM Market in Diagnostic Centers, by Region, Through 2022 ($ Millions)
  • Table 23 Global CGM Market in Hospital Setting, by Region, Through 2022 ($ Millions)
  • Table 24 U.S. CGM Market, by End User, Through 2022 ($ Millions)
  • Table 25 Canadian CGM Market, by End User, Through 2022 ($ Millions)
  • Table 26 European CGM Market, by End User, Through 2022 ($ Millions)
  • Table 27 Asian CGM Market, by End User, Through 2022 ($ Millions)
  • Table 28 ROW CGM Market, by End User, Through 2022 ($ Millions)
  • Table 29 Global CGM Market, by Type of Diabetes, Through 2022, ($ Millions)
  • Table 30 Global CGM Market for T1D, by Region, Through 2022 ($ Millions)
  • Table 31 Global CGM Market for T2D, by Region, Through 2022 ($ Millions)
  • Table 32 Global CGM Market for Gestational Diabetes, by Region, Through 2022 ($ Millions)
  • Table 33 Global CGM Market for Other Diabetes, by Region, Through 2022 ($ Millions)
  • Table 34 U.S. CGM Market, by Type of Diabetes, Through 2022, ($ Millions)
  • Table 35 Canadian CGM Market, by Type of Diabetes, Through 2022, ($ Millions)
  • Table 36 European CGM Market, by Type of Diabetes, Through 2022, ($ Millions)
  • Table 37 Asian CGM Market, by Type of Diabetes, Through 2022, ($ Millions)
  • Table 38 ROW CGM Market, by Type of Diabetes, Through 2022, ($ Millions)
  • Table 39 Global SMBG and Test Strips Market, by Type of Diabetes, Through 2022 ($ Millions)
  • Table 40 U.S. SMBG and Test Strips Market, by Type of Diabetes, Through 2022 ($ Millions)
  • Table 41 Canadian SMBG and Test Strips Market, by Type of Diabetes, Through 2022 ($ Millions)
  • Table 42 European SMBG and Test Strips Market, by Type of Diabetes, Through 2022 ($ Millions)
  • Table 43 Asian SMBG and Test Strips Market, by Type of Diabetes, Through 2022 ($ Millions)
  • Table 44 ROW SMBG and Test Strips Market, by Type of Diabetes, Through 2022 ($ Millions)
  • Table 45 Global CGM Market, by User's Age, Through 2022, ($ Millions)
  • Table 46 U.S. CGM Market, by User's Age, Through 2022, ($ Millions)
  • Table 47 Canadian CGM Market, by User's Age, Through 2022, ($ Millions)
  • Table 48 European CGM Market, by User's Age, Through 2022, ($ Millions)
  • Table 49 Asian CGM Market, by User's Age, Through 2022 ($ Millions)
  • Table 50 ROW CGM Market, by User's Age, Through 2022, ($ Millions)
  • Table 51 Global Market for Glucose Monitoring Devices and Diabetes-Related Products, by Region, Through 2022 ($ Millions)
  • Table 52 Global CGM Market, by Region, Through 2022 ($ Millions)
  • Table 53 Global Insulin Pump Market, by Region, Through 2022 ($ Millions)
  • Table 54 Global Insulin Patch Pump Market, by Region, Through 2022 ($ Millions)
  • Table 55 Global Insulin Durable Pump Market, by Region, Through 2022 ($ Millions)
  • Table 56 Global SMBG Meter and Test Strip Market, by Region, Through 2022 ($ Millions)
  • Table 57 Global SMBG Meter Market, by Region, Through 2022 ($ Millions)
  • Table 58 Global Test Strip Market, by Region, Through 2022 ($ Millions)
  • Table 59 U.S. Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, Through 2022 ($ Millions)
  • Table 60 Canadian Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, Through 2022 ($ Millions)
  • Table 61 European Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, Through 2022 ($ Millions)
  • Table 62 Asian Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, Through 2022 ($ Millions)
  • Table 63 ROW Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, Through 2022 ($ Millions)
  • Table 64 Patent Review of CGM and - Diabetes-related Devices or Methods, 2010-2017
  • Table 65 U.S. Market Drivers and Restraints
  • Table 66 Canadian Market Drivers and Restraints
  • Table 67 European Market Drivers and Restraints
  • Table 68 Asian Market Drivers and Restraints
  • Table 69 ROW Market Drivers and Restraints
  • Table 70 Abbreviations Used in Continuous Glucose Monitoring and - Diabetes-related Devices-
  • Table 71 Glossary of Terms Used in Continuous Glucose Monitoring and - Diabetes-related Devices Market Report-
  • Table 72 Report Sources

List of Figures

  • Summary Figure: Global Market for Continuous Glucose Monitoring Devices and - Diabetes-related Products, by Type, 2016-2022 ($ Millions)
  • Figure 1 History of CGM MARD
  • Figure 2 Juvenile Diabetes Research Foundation's Artificial Pancreas Project Plan, 2013
  • Figure 3 Global Estimates of Undiagnosed Diabetics, IDF Regions, 2015 (%)
  • Figure 4 Global Estimates of Millions of Undiagnosed Diabetics, 2015 (%)
  • Figure 5 Global Diabetes Estimates (Millions)
  • Figure 6 Adult Diabetes Trends, 2015-2040 (Million Cases)
  • Figure 7 Components of One Type of Artificial Pancreas System
  • Figure 8 Global Market for Glucose Monitoring Systems and Diabetes-related Products, by Type, 2016- 2022 ($ Millions)
  • Figure 9 Global Market for CGM Transmitters and Receivers, and Sensors, 2016-2022 ($ Millions)
  • Figure 10 Global Market for Insulin Patch Pumps and Durable Pumps, 2016-2022 ($ Millions)
  • Figure 11 Global Market for SMBG Meters and Test Strips, 2016-2022 ($ Millions)
  • Figure 12 Global CGM Market in Home Setting, by Region, 2016-2022 ($ Millions)
  • Figure 13 Global CGM Market in Diagnostic Centers, by Region, 2016-2022 ($ Millions)
  • Figure 14 Global CGM Market in Hospital Setting, by Region, 2016-2022 ($ Millions)
  • Figure 15 U.S. CGM Market, by End User, 2016-2022 ($ Millions)
  • Figure 16 Canadian CGM Market, by End User, 2016-2022 ($ Millions)
  • Figure 17 European CGM Market, by End User, 2016-2022 ($ Millions)
  • Figure 18 Asian CGM Market, by End User, 2016-2022 ($ Millions)
  • Figure 19 ROW CGM Market, by End User, 2016-2022 ($ Millions)
  • Figure 20 Global CGM Market, by Type of Diabetes, 2016-2022, ($ Millions)
  • Figure 21 Global CGM Market for T1D, by Region, 2016-2022 ($ Millions)
  • Figure 22 Global CGM Market for T2D, by Region, 2016-2022 ($ Millions)
  • Figure 23 Global CGM Market for Gestational Diabetes, by Region, 2016-2022 ($ Millions)
  • Figure 24 Global CGM Market for Other Diabetes, by Region, 2016-2022 ($ Millions)
  • Figure 25 U.S. CGM Market, by Type of Diabetes, 2016-2022, ($ Millions)
  • Figure 26 Canadian CGM Market, by Type of Diabetes, 2016-2022, ($ Millions)
  • Figure 27 European CGM Market, by Type of Diabetes, 2016-2022, ($ Millions)
  • Figure 28 Asian CGM Market, by Type of Diabetes, 2016-2022, ($ Millions)
  • Figure 29 ROW CGM Market, by Type of Diabetes, 2016-2022, ($ Millions)
  • Figure 30 Global SMBG and Test Strips Market, by Type of Diabetes, 2016-2022 ($ Millions)
  • Figure 31 U.S. SMBG and Test Strips Market, by Type of Diabetes, 2016-2022 ($ Millions)
  • Figure 32 Canadian SMBG and Test Strips Market, by Type of Diabetes, 2016-2022 ($ Millions)
  • Figure 33 European SMBG and Test Strips Market, by Type of Diabetes, 2016-2022 ($ Millions)
  • Figure 34 Asian SMBG and Test Strips Market, by Type of Diabetes, 2016-2022 ($ Millions)
  • Figure 35 ROW SMBG and Test Strips Market, by Type of Diabetes, 2016-2022 ($ Millions)
  • Figure 36 Global CGM Market, by User's Age, 2016-2022, ($ Millions)
  • Figure 37 U.S. CGM Market, by User's Age, 2016-2022, ($ Millions)
  • Figure 38 Canadian CGM Market, by User's Age, 2016-2022, ($ Millions)
  • Figure 39 European CGM Market, by User's Age, 2016-2022, ($ Millions)
  • Figure 40 Asian CGM Market, by User's Age, 2016-2022, ($ Millions)
  • Figure 41 ROW CGM Market, by User's Age, 2016-2022, ($ Millions)
  • Figure 42: Global Market for Glucose Monitoring Devices and Diabetes-Related Products, by Region, 2016-2022 ($ Millions)
  • Figure 43 Global CGM Market, by Region, 2016-2022 ($ Millions)
  • Figure 44 Global Insulin Pump Market, by Region, 2016-2022 ($ Millions)
  • Figure 45 Global Insulin Patch Pump Market, by Region, 2016-2022 ($ Millions)
  • Figure 46 Global Insulin Durable Pump Market, by Region, 2016-2022 ($ Millions).
  • Figure 47 Global Patch vs. Durable Pump Market, by Region, 2016 and 2022 (%)
  • Figure 48 Global SMBG Meters and Test Strips Market, by Region, 2016-2022 ($ Millions)
  • Figure 49 Global SMBG Meter Market, by Region, 2016-2022 ($ Millions)
  • Figure 50 Global Test Strip Market, by Region, 2016-2022 ($ Millions)
  • Figure 51 U.S. Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, 2016- 2022
  • Figure 52 Canadian Markets for Glucose Monitoring Devices and Diabetes-Related Products, by Type, 2016-2022 ($ Millions)
  • Figure 53 European Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, 2016-2022 ($ Millions)
  • Figure 54 Asian Markets for Glucose Monitoring Devices and Diabetes-Related Products, by Type, 2016- 2022 ($ Millions)
  • Figure 55 ROW Market for Glucose Monitoring Devices and Diabetes-Related Products, by Type, 2016- 2022 ($ Millions)
  • Figure 56 Medtronic Groups' Shares of FY 2017 Revenues
  • Figure 57 The NovioSense Glucose sensor
Back to Top